| Announce Date | 11/14/2025 |
| EPS Normalized Actual | $-0.18 (Miss by $-0.07) |
| EPS GAAP Actual | $-0.18 (Miss by $-0.07) |
| Revenue Actual | $0.000242B |
| Revenue Surprise | Beat by $0.242M |
| Announce Date | 03/31/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.37 |
| EPS GAAP Estimate | $0.37 |
| Revenue Estimate | $0.043268B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 20.15 | 0.09 | 16.96193 | 24.23051 | 1 |
| Dec 2028 | 0.99 | 1.83 | 0.99 | 0.99 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.27 | -0.27 | 0.000242B | 100% | 0.24M |
| FQ2 2025 (Jun 2025) | -0.98 | -0.98 | 0B | NAN% | 0M |
| FQ1 2025 (Mar 2025) | -0.34 | -0.34 | 0B | NAN% | 0M |
| FQ4 2024 (Dec 2024) | -0.86 | -0.86 | 0B | NAN% | 0M |
| FQ3 2024 (Sep 2024) | -0.15 | -0.15 | 0B | NAN% | 0M |
| FQ2 2024 (Jun 2024) | -0.0008 | -0.0008 | 0B | NAN% | 0M |
| FQ1 2024 (Mar 2024) | -0.74 | -0.74 | 0B | NAN% | 0M |
| FQ4 2023 (Dec 2023) | -0.0516 | -0.0516 | 0B | NAN% | 0M |
FQ4 Announce Date
03/31/2026 (Pre-Market)
Consensus EPS Estimates
0.37
Consensus Revenue Estimates
0.043268B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 4.4 | -- | 4.09895 | 4.70105 | 1 |
| FQ2 2029 (Jun 2029) | 4.41 | -- | 4.10826 | 4.71174 | 1 |
| FQ1 2029 (Mar 2029) | 4.24 | -- | 3.94989 | 4.53011 | 1 |
| FQ4 2028 (Dec 2028) | 2.2567 | -- | 2.2567 | 2.2567 | 1 |
| FQ3 2028 (Sep 2028) | 2.172 | -- | 2.172 | 2.172 | 1 |
| FQ2 2028 (Jun 2028) | 2.1742 | -- | 2.1742 | 2.1742 | 1 |
| FQ1 2028 (Mar 2028) | 2.0893 | -- | 2.0893 | 2.0893 | 1 |
| FQ4 2027 (Dec 2027) | 1.0485 | -- | 1.0485 | 1.0485 | 1 |
| FQ3 2027 (Sep 2027) | 1.0092 | -- | 1.0092 | 1.0092 | 1 |
| FQ2 2027 (Jun 2027) | 1.0102 | -- | 1.0102 | 1.0102 | 1 |
| FQ1 2027 (Mar 2027) | 0.9708 | -- | 0.9708 | 0.9708 | 1 |
| FQ4 2026 (Dec 2026) | 0.2857 | -- | 0.2857 | 0.2857 | 1 |
| FQ3 2026 (Sep 2026) | 0.275 | 198.18 | 0.275 | 0.275 | 1 |
| FQ2 2026 (Jun 2026) | 0.2753 | 455.98 | 0.2753 | 0.2753 | 1 |
| FQ1 2026 (Mar 2026) | 0.37 | 191.89 | 0.37 | 0.37 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 0.56B | -- | 0.53B | 0.59B | 1 |
| FQ2 2029 (Jun 2029) | 0.56B | -- | 0.53B | 0.59B | 1 |
| FQ1 2029 (Mar 2029) | 0.53B | -- | 0.51B | 0.56B | 1 |
| FQ4 2028 (Dec 2028) | 0.27B | -- | 0.27B | 0.27B | 1 |
| FQ3 2028 (Sep 2028) | 0.26B | -- | 0.26B | 0.26B | 1 |
| FQ2 2028 (Jun 2028) | 0.26B | -- | 0.26B | 0.26B | 1 |
| FQ1 2028 (Mar 2028) | 0.25B | -- | 0.25B | 0.25B | 1 |
| FQ4 2027 (Dec 2027) | 0.13B | -- | 0.13B | 0.13B | 1 |
| FQ3 2027 (Sep 2027) | 0.13B | -- | 0.13B | 0.13B | 1 |
| FQ2 2027 (Jun 2027) | 0.13B | -- | 0.13B | 0.13B | 1 |
| FQ1 2027 (Mar 2027) | 0.12B | -- | 0.12B | 0.12B | 1 |
| FQ4 2026 (Dec 2026) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ3 2026 (Sep 2026) | 0.05B | 99.46 | 0.05B | 0.05B | 1 |
| FQ2 2026 (Jun 2026) | 0.05B | -- | 0.05B | 0.05B | 1 |
| FQ1 2026 (Mar 2026) | 0.04B | -- | 0.04B | 0.04B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
1
Revenue # of Misses
0
Revenue # of in-lines
7
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.27 | -0.27 | 100% | |
| FQ2 2025 (Jun 2025) | -0.98 | -0.98 | 100% | |
| FQ1 2025 (Mar 2025) | -0.34 | -0.34 | 100% | |
| FQ4 2024 (Dec 2024) | -0.86 | -0.86 | 100% | |
| FQ3 2024 (Sep 2024) | -0.15 | -0.15 | 100% | |
| FQ2 2024 (Jun 2024) | -0.0008 | -0.0008 | 100% | |
| FQ1 2024 (Mar 2024) | -0.74 | -0.74 | 100% | |
| FQ4 2023 (Dec 2023) | -0.0516 | -0.0516 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0.24M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0M | NAN% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $0B | $0M | NAN% |
| FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
| FQ2 2024 (Jun 2024) | $0B | $0B | $0M | NAN% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |